Shandong Xinhua Pharmaceutical Company Limited Cash Flow Conversion Efficiency
Shandong Xinhua Pharmaceutical Company Limited cash flow conversion efficiency. Based on the latest financial reports, Shandong Xinhua Pharmaceutical Company Limited (XIN) has a cash flow conversion efficiency ratio of 0.012x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€56.11 Million ≈ $65.60 Million USD) by net assets (€4.70 Billion ≈ $5.50 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Cash flow conversion efficiency of Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2025. This chart illustrates how Shandong Xinhua Pharmaceutical Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shandong Xinhua Pharmaceutical Company L (XIN) share price today for real-time trading data and today's change.
Shandong Xinhua Pharmaceutical Company Limited Cash Flow Conversion Ratio Explained
Shandong Xinhua Pharmaceutical Company Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shandong Xinhua Pharmaceutical Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Xinhua Pharmaceutical Company Limited ranked by their cash flow conversion efficiency. Also see Shandong Xinhua Pharmaceutical Company L market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cheops Technology France SA
PA:MLCHE
|
N/A |
|
Mega Uranium Ltd.
TO:MGA
|
-0.005x |
|
SPRINGFIELD PROP. LS-125
F:9MZ
|
N/A |
|
Walchandnagar Industries Limited
NSE:WALCHANNAG
|
0.034x |
|
Kustur Kusadasi Turizm Endustrisi AS
IS:KSTUR
|
0.056x |
|
S&P Syndicate Public Company Limited
BK:SNP
|
0.106x |
|
EDAP TMS S.A
F:EDA
|
1.144x |
|
Silicon Optronics Inc
TW:3530
|
0.056x |
Annual Cash Flow Conversion Efficiency for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
The table below shows the annual cash flow conversion efficiency of Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2025. Review Shandong Xinhua Pharmaceutical Company L (XIN) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €5.46 Billion ≈ $6.38 Billion |
€533.73 Million ≈ $623.98 Million |
0.098x | +38.85% |
| 2024-12-31 | €5.22 Billion ≈ $6.10 Billion |
€367.61 Million ≈ $429.78 Million |
0.070x | +26.84% |
| 2023-12-31 | €4.78 Billion ≈ $5.58 Billion |
€265.28 Million ≈ $310.14 Million |
0.056x | -68.13% |
| 2022-12-31 | €4.35 Billion ≈ $5.09 Billion |
€758.24 Million ≈ $886.46 Million |
0.174x | +145.62% |
| 2021-12-31 | €3.65 Billion ≈ $4.27 Billion |
€259.12 Million ≈ $302.93 Million |
0.071x | -42.72% |
| 2020-12-31 | €3.39 Billion ≈ $3.96 Billion |
€420.19 Million ≈ $491.24 Million |
0.124x | +10.66% |
| 2019-12-31 | €3.11 Billion ≈ $3.64 Billion |
€348.27 Million ≈ $407.17 Million |
0.112x | -3.33% |
| 2018-12-31 | €2.80 Billion ≈ $3.27 Billion |
€323.91 Million ≈ $378.68 Million |
0.116x | -23.39% |
| 2017-12-31 | €2.58 Billion ≈ $3.02 Billion |
€389.97 Million ≈ $455.92 Million |
0.151x | -28.45% |
| 2016-12-31 | €2.08 Billion ≈ $2.43 Billion |
€439.35 Million ≈ $513.64 Million |
0.211x | +20.25% |
| 2015-12-31 | €1.98 Billion ≈ $2.32 Billion |
€348.64 Million ≈ $407.59 Million |
0.176x | -3.00% |
| 2014-12-31 | €1.91 Billion ≈ $2.24 Billion |
€346.34 Million ≈ $404.91 Million |
0.181x | +224.96% |
| 2013-12-31 | €1.88 Billion ≈ $2.20 Billion |
€104.99 Million ≈ $122.75 Million |
0.056x | -- |
About Shandong Xinhua Pharmaceutical Company Limited
Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing service… Read more